Clinical Trial Update: Tomotherapy Treatment for Mesothelioma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Tomotherapy radiation therapy for malignant mesothelioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Mesothelioma

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Mesothelioma | Phase 2 | Status: COMPLETED